RIPK3 Anticorps
(Receptor-Interacting serine-threonine Kinase 3 (RIPK3))
Choisissez l’un des 107 anticorps RIPK3 de notre liste de produits basés sur 9 publications et 74 images de validation.
Découvrez des anticorps RIPK3 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de RIPK3 dans plusieurs espèces, y compris Human, Mouse, Rat, Monkey, Cow, Pig, Horse, Dog, et prend en charge diverses applications de recherche telles que WB, IHC, ELISA, IF, IHC (p).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants RIPK3, issus de différents hôtes tels que Rabbit, Mouse. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de RIPK3 sont RIPK3, ripk3.S, Ripk3.
| Catalog no. | Produit | Reactivité | Hôte / Clonalité | Application | Prix et délai de livraison |
|---|---|---|---|---|---|
| RIPK3 anticorps (N-Term) (FITC) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| RIPK3 anticorps (N-Term) (Fluoro550) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| RIPK3 anticorps (N-Term) (Cy3) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| RIPK3 anticorps (N-Term) (Fluoro488) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| RIPK3 anticorps (N-Term) (Fluoro594) | Humain | Lapin Polyclonal |
|
742,50 €
Voir le prix
|
|
| RIPK3 anticorps (N-Term) (Fluoro647) | Humain | Lapin Polyclonal |
|
852,50 €
Voir le prix
|
|
| RIPK3 anticorps (N-Term) (PE) | Humain | Lapin Polyclonal |
|
1.017,50 €
Voir le prix
|
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- FITC
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro550
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Cy3
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro488
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro594
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- Fluoro647
- Isotype
- IgG
- Epitope
- N-Term
Primary Antibody
- WB (Western Blotting: Application indiquée)
- Reactivité
- Humain
- Hôte
- Lapin
- Clonalité
- Polyclonal
- Conjugué
- PE
- Isotype
- IgG
- Epitope
- N-Term
Dernières publications pour nos RIPK3 Anticorps
: "Necroptosis mediated by receptor interacting protein kinase 3 as critical players in experimental congenital hypothyroidism related neuronal damage." dans: Northern clinics of Istanbul, Vol. 8, Issue 5, pp. 472-478, (2021) (PubMed).
: "Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation." dans: The Journal of allergy and clinical immunology, Vol. 143, Issue 1, pp. 213-228.e10, (2019) (PubMed).
: "Inhibiting of RIPK3 attenuates early brain injury following subarachnoid hemorrhage: Possibly through alleviating necroptosis." dans: Biomedicine & pharmacotherapy, Vol. 107, pp. 563-570, (2019) (PubMed).
: "The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia-reperfusion." dans: Acta biochimica et biophysica Sinica, Vol. 50, Issue 11, pp. 1131-1140, (2019) (PubMed).
: "TAK1 regulates endothelial cell necroptosis and tumor metastasis." dans: Cell death and differentiation, (2019) (PubMed).
: "O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3." dans: Immunity, Vol. 50, Issue 3, pp. 576-590.e6, (2019) (PubMed).
: "TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma." dans: Cell death and differentiation, (2019) (PubMed).
: "DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties." dans: Translational oncology, Vol. 12, Issue 7, pp. 932-950, (2019) (PubMed).
: "Post-ischemic salubrinal administration reduces necroptosis in a rat model of global cerebral ischemia." dans: Journal of neurochemistry, (2019) (PubMed).
: "Central nervous system regeneration is driven by microglia necroptosis and repopulation." dans: Nature neuroscience, Vol. 22, Issue 7, pp. 1046-1052, (2019) (PubMed).
: "Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation." dans: The Journal of allergy and clinical immunology, Vol. 143, Issue 1, pp. 213-228.e10, (2019) (PubMed).
: "Inhibiting of RIPK3 attenuates early brain injury following subarachnoid hemorrhage: Possibly through alleviating necroptosis." dans: Biomedicine & pharmacotherapy, Vol. 107, pp. 563-570, (2019) (PubMed).
: "The role of RIP3 in cardiomyocyte necrosis induced by mitochondrial damage of myocardial ischemia-reperfusion." dans: Acta biochimica et biophysica Sinica, Vol. 50, Issue 11, pp. 1131-1140, (2019) (PubMed).
: "TAK1 regulates endothelial cell necroptosis and tumor metastasis." dans: Cell death and differentiation, (2019) (PubMed).
: "O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3." dans: Immunity, Vol. 50, Issue 3, pp. 576-590.e6, (2019) (PubMed).
: "TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma." dans: Cell death and differentiation, (2019) (PubMed).
: "DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties." dans: Translational oncology, Vol. 12, Issue 7, pp. 932-950, (2019) (PubMed).
: "Post-ischemic salubrinal administration reduces necroptosis in a rat model of global cerebral ischemia." dans: Journal of neurochemistry, (2019) (PubMed).
: "Central nervous system regeneration is driven by microglia necroptosis and repopulation." dans: Nature neuroscience, Vol. 22, Issue 7, pp. 1046-1052, (2019) (PubMed).
Pseudonymes pour RIPK3 Anticorps
receptor interacting serine/threonine kinase 3 (RIPK3) Anticorpsreceptor interacting serine/threonine kinase 3 S homeolog (ripk3.S) Anticorps
receptor-interacting serine-threonine kinase 3 (Ripk3) Anticorps
receptor interacting serine/threonine kinase 3 (Ripk3) Anticorps
2610528K09Rik Anticorps
AW107945 Anticorps
Hcyp2 Anticorps
RIP3 Anticorps
Rip3 Anticorps
RIPK3 Anticorps
Avez-vous cherché autre chose?
- RIPK2 Anticorps
- RIPK1 Anticorps
- RIP2 Anticorps
- RIOK3 Anticorps
- RIOK2 Anticorps
- RIOK1 Anticorps
- RINT1 Anticorps
- Ring Finger Protein 8 Anticorps
- Ring Finger Protein 34 Anticorps
- Ring Finger Protein 11 Anticorps
- Ring Finger Protein 1 Anticorps
- RIN3 Anticorps
- RIN2 Anticorps
- RIN1 Anticorps
- RIMS4 Anticorps
- RIMS3 Anticorps
- RIMS2 Anticorps
- RIMKLB Anticorps
- RIMKLA Anticorps
- RIMBP2 Anticorps
- RIPK4 Anticorps
- RIPPLY2 Anticorps
- RIT1 Anticorps
- RIT2 Anticorps
- RLF Anticorps
- RLIM Anticorps
- RMDN3 Anticorps
- RMI1 Anticorps
- RMI2 Anticorps
- RMND1 Anticorps
- RMND5A Anticorps
- RNA Binding Motif Protein 24 Anticorps
- RNA Binding Motif Protein 8A Anticorps
- RNA Methyltransferase Like 1 Anticorps
- RNA Polymerase II Subunit RPB1 Anticorps
- RNASE1 Anticorps
- RNASE10 Anticorps
- RNASE11 Anticorps
- RNASE13 Anticorps
- RNASE2 Anticorps
Vous êtes ici:
